NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 82 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $99,000 | -32.2% | 720,207 | -50.0% | 0.00% | – |
| Q4 2018 | $146,000 | -12.0% | 1,440,414 | +100.0% | 0.00% | – |
| Q3 2018 | $166,000 | +1.2% | 720,207 | 0.0% | 0.00% | – |
| Q2 2018 | $164,000 | -36.7% | 720,207 | 0.0% | 0.00% | – |
| Q1 2018 | $259,000 | +0.4% | 720,207 | 0.0% | 0.00% | – |
| Q4 2017 | $258,000 | -13.4% | 720,207 | 0.0% | 0.00% | – |
| Q3 2017 | $298,000 | -18.8% | 720,207 | 0.0% | 0.00% | – |
| Q2 2017 | $367,000 | -11.6% | 720,207 | 0.0% | 0.00% | – |
| Q1 2017 | $415,000 | -8.2% | 720,207 | 0.0% | 0.00% | – |
| Q4 2016 | $452,000 | -31.4% | 720,207 | 0.0% | 0.00% | – |
| Q3 2016 | $659,000 | +72.5% | 720,207 | 0.0% | 0.00% | – |
| Q2 2016 | $382,000 | -51.0% | 720,207 | -12.8% | 0.00% | – |
| Q1 2016 | $779,000 | -28.2% | 825,766 | +1.2% | 0.00% | -100.0% |
| Q4 2015 | $1,085,000 | -39.1% | 816,158 | +4.4% | 0.00% | 0.0% |
| Q3 2015 | $1,783,000 | +48.5% | 782,059 | +4.8% | 0.00% | 0.0% |
| Q2 2015 | $1,201,000 | +1.7% | 746,488 | +0.5% | 0.00% | 0.0% |
| Q1 2015 | $1,181,000 | -15.9% | 742,947 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,404,000 | +53.4% | 742,947 | +7.1% | 0.00% | 0.0% |
| Q3 2014 | $915,000 | -7.7% | 693,444 | +3.5% | 0.00% | 0.0% |
| Q2 2014 | $991,000 | -15.7% | 670,229 | +5.5% | 0.00% | 0.0% |
| Q1 2014 | $1,175,000 | -7.8% | 635,233 | +3.2% | 0.00% | 0.0% |
| Q4 2013 | $1,274,000 | -8.3% | 615,690 | +17.5% | 0.00% | 0.0% |
| Q3 2013 | $1,389,000 | +2.5% | 523,969 | +3.2% | 0.00% | 0.0% |
| Q2 2013 | $1,355,000 | – | 507,622 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|